Cloxacilina [INN-Spanish] en es it fr

Cloxacilina [INN-Spanish] Brand names, Cloxacilina [INN-Spanish] Analogs

Cloxacilina [INN-Spanish] Brand Names Mixture

  • No information avaliable

Cloxacilina [INN-Spanish] Chemical_Formula


Cloxacilina [INN-Spanish] RX_link

No information avaliable

Cloxacilina [INN-Spanish] fda sheet

Cloxacilina [INN-Spanish] msds (material safety sheet)

Cloxacilina_[INN-Spanish] MSDS

Cloxacilina [INN-Spanish] Synthesis Reference

No information avaliable

Cloxacilina [INN-Spanish] Molecular Weight

435.882 g/mol

Cloxacilina [INN-Spanish] Melting Point

No information avaliable

Cloxacilina [INN-Spanish] H2O Solubility

13.9 mg/L

Cloxacilina [INN-Spanish] State


Cloxacilina [INN-Spanish] LogP


Cloxacilina [INN-Spanish] Dosage Forms

Capsules (250 mg, 500 mg); Powder (125 mg/5 mL when reconstituted)

Cloxacilina [INN-Spanish] Indication

Used to treat infections caused by penicillinase-producing staphylococci, including pneumococci, group A beta-hemolytic streptococci, and penicillin G-sensitive and penicillin G-resistant staphylococci.

Cloxacilina [INN-Spanish] Pharmacology

Cloxacillin is a semisynthetic antibiotic in the same class as penicillin. Cloxacillin is for use against staphylococci that produce beta-lactamase.

Cloxacilina [INN-Spanish] Absorption

Well absorbed from the gastrointestinal tract.

Cloxacilina [INN-Spanish] side effects and Toxicity

Oral LD50 in rat and mouse is 5000 mg/kg. Intravenous LD50 in rat is 1660 mg/kg. Symptoms of overdose include wheezing, tightness in the chest, fever, itching, bad cough, blue skin color, fits, and swelling of face, lips, tongue, or throat.

Cloxacilina [INN-Spanish] Patient Information

Cloxacilina [INN-Spanish] Organisms Affected

Enteric bacteria and other eubacteria